Navigation Links
Essilor : First Half 2009 Results
Date:8/26/2009

es and in the scope of consolidation 15

Net debt increased by EUR99 million to EUR211 million, from EUR112 million at year-end 2008 as the Company' high profitability and robust performance enabled it to pursue an ambitious financial investment program involving acquisitions and share buybacks and to increase dividends. Net debt was also affected by the seasonal impact of annual discount payments to customers, which are generally concentrated in the first half. Net cash flow (cash flow less capital expenditure) rose by 12.5% to EUR99 million.

Related party transactions / Risks and contingencies

In first-half 2009, the nature of transactions with companies consolidated by the proportionate or equity method was not significantly different from the description in the 2008 Registration Document. Similarly, risks and contingencies to which the Company is exposed in the months ahead are generally in line with the analysis presented in Chapter 4 of the Registration Document.

Outlook

In the second half of the year, Essilor will continue to grow the business, leveraging the quality of its products and its services to opticians, backed by an acquisitions strategy that extends across all regions. The Company will also pursue its efforts to maintain a high operating margin. Over the full year, Essilor expects to strengthen its presence in all markets.

(1)Application of IFRS 8 - Operating Segments has resulted in the creation of the "Laboratory Equipment" business segment, which includes the machines, consumables and replacement parts sold by Satisloh and Delamare to prescription laboratories. The change has not has a material impact on revenue from the operating regions, which consolidate all of the other sales (primarily of ophthalmic lenses and optical instruments).

    ------------------------------

  
'/>"/>
SOURCE Essilor
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
2. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
3. Essilor Enters Bulgarian Market
4. Essilor : 2007 Results
5. Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
6. Essilors 2008 First-Quarter Report
7. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
8. Essilor - First-Half 2008 Revenue
9. Essilor Steps Up its Development in Eastern Europe
10. Essilor Agrees to Acquire Signet Armorlite
11. Essilor : 2008 Revenue

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...cer patients and survivors treated with chemothera...ecome chronic conditions, hindering patients, abil...he University of Rochester Medical Center. , A s...d sleep troubles at nearly three times the rate of...alent in younger patients and those with lung and ...
(Date:11/23/2009)...s getting chemo deal with insomnia, study shows ,...somnia and sleep disorders affect more than three-...y, a rate nearly three times higher than that of t... problem is more common in younger patients and in...ty of Rochester Medical Center researchers, who as...
(Date:11/23/2009)....,Nov.23/PRNewswire/--Hazelden,theinternationallyr...uncedtheleadershipteamforitsnewrecoverycenterinNap...duledtoopeninlateMarch2010,andwillinitiallyprovide...arrayoffamilyandoutpatientservices. ,, MichaelD...,sfacilityinNaples,withBrendaIliff,M.A.,L.A.D.C.,a...
(Date:11/23/2009)...23/PRNewswire-USNewswire/-- The AmericanLegislati...ualmembershipassociationofstatelegislators,congrat...rpre-filinga constitutionalamendment toprotectther...outhCarolinanowbecomesthe24thstatewherelegislators...fterALEC,s FreedomofChoiceinHealthCareAct . ,, ...
(Date:11/23/2009)...nter for Science Writings at Stevens Institute of ...talk by Robert Wright, journalist and founder, Blo...:30 p.m. at the Babbio Center for Technology Manag... public and the media., In his new book "The Evo...Wright, renowned for his popular works on evolutio...
Breaking Medicine News(10 mins):Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:South Carolina Now 24th State to Defend Health Care Choice 2
...e 16 BlueCross BlueShield,of South Carolina this ...f,the company,s health insurance plans that also a...viduals seeking more options., "With increasing h..." said BlueCross BlueShield Division President,Dav...
....D., director of the Duke Comprehensive Cancer Cen...ational Cancer Advisory Board. , Lyerly was one ... 2008. , The National Cancer Advisory Board is an...an Services and the director of the NCI on issues...
...IMMEDIATE RELEASE , Coffee,s aroma kick-starts g...od Chemistry , Drink coffee to send a wake-up ca...a? An international group of scientists is reporti...ound that coffee aroma orchestrates the expression...
...grated preclinical contract research provider base...leading early phase clinical trial facility in Aus...e alliance aims to enhance the delivery of bioanal...s, which are both commercialisation enterprises of...
...ntrol of risk factors, less likely to get choleste...lthDay News) -- Women with type 2 diabetes and hea...ment they need than men, making their ability to c...ng in San Francisco, probably explains why death f...
... Allows Verus to Focus Solely on AstraZeneca ...June 16 Verus Pharmaceuticals, Inc., a,pediatric-...ed today that,Meritage Pharma, Inc., a newly forme...ovel formulation of an existing,molecule intended ...
Other Medicine News:Health News:S.C. BlueCross Launches Less-Costly Plans Geared to Groups Seeking More Options 2Health News:American Chemical Society's Weekly PressPac: June 11, 2008 2Health News:American Chemical Society's Weekly PressPac: June 11, 2008 3Health News:American Chemical Society's Weekly PressPac: June 11, 2008 4Health News:American Chemical Society's Weekly PressPac: June 11, 2008 5Health News:American Chemical Society's Weekly PressPac: June 11, 2008 6Health News:American Chemical Society's Weekly PressPac: June 11, 2008 7Health News:American Chemical Society's Weekly PressPac: June 11, 2008 8Health News:TetraQ and Q-Pharm form strategic alliance 2Health News:TetraQ and Q-Pharm form strategic alliance 3Health News:Less Intensive Treatment Given Diabetic Women With Heart Disease 2Health News:Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma 2Health News:Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma 3
(Date:11/23/2009)...er.comannouncesthatanewmarketresearchreportisavail...cImagingMarketto2015 ,, http://www.reportlin...ing-Market-to-2015.html#utm_source=prnewswire&..., Description ,, TheFutureoftheDiagnosticImag...sDirect,s"TheFutureoftheDiagnosticImagingMarketto2...
(Date:11/23/2009)...tCall/--AMICAS,Inc.(Nasdaq: AMCS ),aleaderinimagea...titwillhighlightitsenterpriseimagingautomationsolu...NA)annualmeetingfromNovember29toDecember4inChicago...(Logo: http://www.newscom.com/cgi-bin/prnh/2006020...abouthealthcarereform,thereisanunprecedentedintere...
(Date:11/23/2009)...er.comannouncesthatanewmarketresearchreportisavail...WorldMarketReview ,, http://www.reportlinker...ket-Review.html#utm_source=prnewswire&utm_medi...generalanesthesiadisposablesmarketischaracterizedb...ewitnessedingeneralsurgicalprocedures,growingpopul...
Breaking Medicine Technology:Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 3Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 4Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 5Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 7Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 8Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 9Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 10Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 11AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 2AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 3Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Spanish Broadcasting System and 93 3 La Raza to Hold Radiothon for Childrens Hospital 26 Research Center Oakland 52739 1Spanish Broadcasting System and 93 3 La Raza to Hold Radiothon for Childrens Hospital 26 Research Center Oakland 52739 2Video 3A New Dove 28R 29 Body Washes with NutriumMoisture 28TM 29 Restore Skins Natural Moisture 4780 1Video 3A New Dove 28R 29 Body Washes with NutriumMoisture 28TM 29 Restore Skins Natural Moisture 4780 2Video 3A New Dove 28R 29 Body Washes with NutriumMoisture 28TM 29 Restore Skins Natural Moisture 4780 3Video 3A New Dove 28R 29 Body Washes with NutriumMoisture 28TM 29 Restore Skins Natural Moisture 4780 4Solace Pharmaceuticals Appoints Professor David Julius Renowned Pain Physiologist to Scientific Advisory Board 13196 1Solace Pharmaceuticals Appoints Professor David Julius Renowned Pain Physiologist to Scientific Advisory Board 13196 2Solace Pharmaceuticals Appoints Professor David Julius Renowned Pain Physiologist to Scientific Advisory Board 13196 3
...reduce trial delivery time and ensure faster acces... CLEVELAND, Jan. 30 DATATRAK International,Inc. ...y focused on global,eClinical solutions for the cl...asing options, flexibility and efficiency for end-...ase., Some of the new interactive features and...
...alif., Jan. 30 Nuvelo, Inc.,(Nasdaq: NUVO ) toda... in a,single-center, Phase 1 trial to determine th...alating doses of NU172, a thrombin-inhibiting,apta... "This proof-of-concept trial will allow us to qu... onset and offset of anticoagulation," said,Michae...
Other Medicine Technology:DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 2DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 3DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 4DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 5Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172 2Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172 3
Quantaphase II B12/RIA
Autoimmunity Screening Panel 1
...laboratories that have decided to change to the EL...the RELISA ANAs correlation with IFA and many user...ompetition. While no ELISA ANA currently on the ma...RELISA ANA screen has been shown to be quite effec...
...2000 ANA uses a patented HEp-2 cell line that has ...ivity to SS-A/Ro autoantibodies, without affecting...studies have been published worldwide on the HEp-2...y to SS-A/Ro autoantibodies when used in place of ...
Medicine Products: